CBD	Cannabidiol
MASLD	Metabolic dysfunction-associated steatotic liver disease
NAFLD	non-alcoholic fatty liver disease
CB1	cannabinoid receptor 1
CB2	cannabinoid receptor 2
PPARs	peroxisome proliferator-activated receptors
TRPs	transient receptor potential channels
HCC	hepatocellular carcinoma
HFD	high-fat diet
TGF-β	transforming growth factor-β
PPAR γ	peroxisome proliferator-activated receptor γ
PPARα	peroxisome proliferator-activated receptor α
NF-κB	nuclear factor kappa-light-chain-enhancer of activated B cells
AMPK	5′AMP-activated protein kinase
ACC	Acetyl-coenzyme A carboxylase
NLRP3	NLR family pyrin domain containing 3
TRPV1	Transient receptor potential vanilloid 1
TRPV2	Transient receptor potential vanilloid 2
TRPA1	Transient receptor potential ankyrin 1
TRPM8	Transient receptor potential melastatin 8
GPR55	G protein-coupled receptor 55
2H2-CBD	deuterium-labelled cannabidiol
HSCs	hepatic stellate cells
GSDME	gasdermin E
COX-2	cyclooxygenase-2
LSECs	liver sinusoidal cells
AEA	anandamide
2-AG	2-arachidonoylglycerol
AA	arachidonic acid
LPI	L-α-lysophosphatidylinositol
Abn-CBD	abnormal cannabidiol
APAP	acetaminophen
NASH	non-alcoholic steatohepatitis
RA-FLS	Rheumatoid Arthritis Fibroblast-like Synoviocytes
LTs	liver tests